#Medical Nasogastric Tubes Market Growth

[farmacuticals]

Feeding Tube Market Overview: Size, Share, and Future Projections for Nutritional Support

A feeding tube is a medical device used to deliver nutrition directly to the stomach or small intestine when a patient is unable to consume food orally. This method is commonly employed in patients with conditions that impair their ability to eat or swallow, such as neurological disorders, gastrointestinal diseases, or certain types of cancers. Feeding tubes come in various types, including nasogastric (NG), gastrostomy (G-tube), and jejunostomy (J-tube), each suited for specific medical needs. The use of feeding tubes has become increasingly essential in hospitals, long-term care facilities, and home care settings, reflecting the growing demand for nutritional support in both acute and chronic conditions.

The feeding tube market size was projected to be 0.53 billion USD in 2022 based on MRFR analysis. By 2032, the feeding tube market is projected to have grown from 0.55 billion USD in 2023 to 0.84 billion USD. During the forecast period (2024-2032), the feeding tube market's compound annual growth rate (CAGR) is anticipated to be approximately 4.8%.

Feeding Tube Size

The Feeding Tube market size is expanding due to the rising incidence of conditions that necessitate nutritional support. With an aging global population and the increasing prevalence of chronic illnesses like cancer, stroke, and neurological disorders, the need for feeding tubes is on the rise. According to market analysis, the global feeding tube market is expected to witness steady growth over the next decade. In particular, the adoption of advanced feeding tubes designed to minimize patient discomfort and reduce the risk of complications is contributing to the market’s expansion. Moreover, improvements in healthcare infrastructure, especially in emerging markets, are driving the growth of the Feeding Tube market size.

Feeding Tube Share

The Feeding Tube market share is distributed across several key segments, including hospitals, home care settings, and long-term care facilities. Hospitals dominate the market share due to the high volume of patients requiring feeding tube placement during acute care and post-surgical recovery. However, home care is a growing segment, as more patients are discharged from hospitals with feeding tubes in place for long-term nutritional support. The market share is also influenced by advancements in tube design, which have improved patient outcomes and reduced the frequency of complications such as infections and blockages. Companies focusing on the development of more efficient and patient-friendly feeding tube systems are gaining a larger Feeding Tube market share.

Feeding Tube Analysis

Feeding Tube market analysis indicates that several factors are contributing to the growth and evolution of this industry. The increasing prevalence of diseases like dysphagia, gastrointestinal disorders, and cancers is driving demand for feeding tubes. Additionally, the rise in the number of surgeries and the need for post-operative nutritional support is boosting the demand for feeding tubes in hospitals and other healthcare settings. Another significant factor highlighted in the Feeding Tube market analysis is the trend toward home-based care, which is driving the development of easy-to-use and portable feeding tube systems that can be managed by caregivers at home. The analysis also suggests that reimbursement policies and insurance coverage for feeding tubes are influencing market growth.

Feeding Tube Trends

Several key trends are shaping the Feeding Tube market. One of the most notable trends is the increasing demand for home care services, as patients and healthcare systems shift towards more cost-effective and convenient care options. This trend is driving innovation in portable and user-friendly feeding tube systems. Another significant trend is the development of advanced materials and designs that improve patient comfort, reduce complications, and enhance the overall efficacy of feeding tubes. Additionally, there is a growing emphasis on infection control, leading to the production of feeding tubes with antimicrobial properties. Finally, the increasing adoption of enteral nutrition therapy in the management of chronic diseases is further contributing to the growth of the Feeding Tube market.

Reasons to Buy the Reports

Comprehensive Market Insights: Reports offer detailed insights into the Feeding Tube market size, share, and growth potential, helping businesses make informed decisions.

Competitive Landscape: Gain an understanding of the key players in the Feeding Tube market and their strategies to maintain or grow their market share.

Emerging Market Trends: Stay updated on the latest Feeding Tube trends, including innovations in tube design and the shift toward home-based care.

Forecasts and Projections: Access accurate market forecasts that guide investment decisions and help businesses anticipate future opportunities in the Feeding Tube market.

Strategic Recommendations: Receive actionable insights and recommendations for entering or expanding in the Feeding Tube market.

Recent Developments in the Feeding Tube Market

Recent developments in the Feeding Tube market include the introduction of feeding tubes made from biocompatible materials that reduce the risk of patient reactions and infections. There has also been significant progress in the design of tubes with smaller diameters, making them more comfortable for long-term use. Additionally, the incorporation of advanced sensors and monitoring systems in feeding tubes has improved the accuracy of nutritional delivery and minimized complications. Another development is the rising adoption of antimicrobial-coated feeding tubes, which help prevent infections, a common issue associated with long-term tube feeding. Lastly, the increasing availability of portable feeding pumps and accessories is supporting the trend toward home-based enteral feeding, providing patients with greater mobility and independence.

Related reports :

first aid market

breast retractor market

fertility tourism market

[industrynewsupdates]

Enteral Feeding Devices Market Key Drivers and Emerging Trends 2024-2030

The global enteral feeding devices market size was valued at USD 4.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2030. 

Growing geriatric population has resulted in increased incidences of diabetes, severe pancreatitis, and other gastrointestinal diseases, which aids market growth. Adoption of the “Feed Early Enteral Diet Adequately for Maximum Effect” (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse balloon designs are also expected to aid in growth during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Enteral Feeding Devices Market

Numerous NCBI studies suggest that people over 65 years pose a higher risk of developing chronic illnesses including Parkinson’s and nervous system disorders. The global population aged 60 years and older is expected to increase from around 1 billion in 2020 to about 1.4 billion in 2030 and is expected to double by 2050 to reach around 2.1 billion. The number of elderly patients with critical illnesses has increased significantly over the past few years. The risk of malnutrition and frailty among the geriatric population with comorbidities, such as stroke, depression, and dementia, is much higher, mainly owing to various age-related changes in body composition and muscle mass. This results in a reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of falls or injuries.

Enteral Feeding Devices Market Segmentation

Grand View Research, Inc. has segmented the global enteral feeding devices market report based on product, age group, indication, end-use, and region:

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Giving Set

• Enteral Feeding Pump

• Percutaneous Endoscopic Gastrostomy Device

• Low Profile Gastrostomy Device

• Nasogastric Tube

• Gastrostomy Tube

Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Adults 

• Pediatrics

Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Alzheimer’s

• Nutrition Deficiency

• Cancer Care

• Diabetes

• Chronic Kidney Diseases

• Orphan Diseases

• Dysphagia

• Pain Management

• Malabsorption/GI Disorder/Diarrhea

• Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

o Cardiology

o Neurology

o Critical Care (ICU)

o Oncology

o Others

• Home Care

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Spain `          

o Italy

o Russia

o Sweden

o Norway

o Denmark

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

o Singapore

• Latin America

o Brazil

o Mexico

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global surgical drills market size was estimated at USD 1.27 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030.

• The global ophthalmic ultrasound devices market size was valued at USD 590.9 million in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2030.

Key Companies & Market Share Insights

The market players are focusing on product development, new technological advancements, and other initiatives to strengthen their market position.

Key Enteral Feeding Devices Companies:

• Conmed Corporation

• C.R.Bard

• Cook Medical

• Boston Scientific Corporation

• Moog Inc.

• Fresenius Kabi AG

• Danone Medical Nutrition

• Kimberly-Clark

• Abbott Nutrition

• B Braun Melsungen AG

• Avanos Medical, Inc.

• Cardinal Health

• Applied Medical Technology, Inc.

• Vygon India

• Fidmi Medical

• ALCOR Scientific

• Amsino International, Inc.

Recent Developments

• In September 2023, Cardinal Health launched Kangaroo OMNI enteral feeding pump, intended to give patients undergoing enteral feeding more options to suit their individual needs over the course of their enteral feeding journey.

• In August 2023, Cardinal Health launched its next-generation NTrainerTM System 2.0, a medical device intended to shorten the length of stay in the neonatal intensive care unit (NICU) for premature and newborn infants by assisting them in developing the oral coordination skills necessary for the transition to independent feeding more quickly. The NTrainerTM System gives parents confidence in their newborns' progress and potential for success after discharge by giving clinicians the objective data they need to monitor an infant's development of pre-feeding skills through real-time assessment technology.

Order a free sample PDF of the Enteral Feeding Devices Market Intelligence Study, published by Grand View Research.

[credenceresearchdotblog]

Global enteral feeding devices market is expected to develop at a compound annual growth rate (CAGR) of 5.20%, from its estimated USD 4551.32 million in 2023 to USD 7182.55 million in 2032.The enteral feeding devices market is experiencing significant growth, driven by a combination of factors such as the increasing prevalence of chronic diseases, rising geriatric population, and advancements in medical technology. These devices, crucial for delivering nutrition directly to the gastrointestinal tract of patients who cannot consume food orally, are becoming indispensable in clinical settings.

Browse the full report at https://www.credenceresearch.com/report/enteral-feeding-devices-market

Market Dynamics

Drivers

1. Increasing Prevalence of Chronic Diseases: The growing incidence of chronic conditions like cancer, neurological disorders, and gastrointestinal diseases necessitates long-term nutritional support. Enteral feeding devices provide a lifeline for these patients, ensuring they receive the required nutrients.

2. Aging Population: The global aging population is a significant market driver. Elderly individuals often face difficulties in swallowing, necessitating enteral feeding. With the proportion of older adults rising, the demand for these devices is set to increase.

3. Technological Advancements: Innovations in enteral feeding devices, such as the development of user-friendly, portable, and highly efficient devices, are propelling market growth. Advanced features like safety alarms, anti-clogging mechanisms, and easy-to-clean designs enhance the appeal of these devices.

4. Shift Towards Home Care: There is a growing trend towards home healthcare due to its cost-effectiveness and convenience. Enteral feeding devices designed for home use are witnessing increased adoption, contributing to market expansion.

Restraints

1. Complications and Risks: The use of enteral feeding devices is associated with certain risks, including infections, tube dislodgement, and blockages. These complications can deter their use, impacting market growth.

2. High Costs: The initial costs of enteral feeding devices and the expenses associated with their maintenance can be high, which may limit their adoption, particularly in low-income regions.

Market Segmentation

The enteral feeding devices market can be segmented based on product type, age group, end-user, and geography.

By Product Type

1. Enteral Feeding Pumps: These are the most commonly used devices due to their precision in nutrient delivery and ease of use. 2. Enteral Feeding Tubes: Including nasogastric tubes, gastrostomy tubes, and jejunostomy tubes, these are essential for direct nutrient delivery to the stomach or small intestine. 3. Administration Sets: These sets are crucial for the delivery of nutrients from the feeding pump to the patient. 4. Other Accessories: Including syringes, giving sets, and connectors, these accessories support the feeding process.

By Age Group

1. Pediatrics: Children with congenital anomalies or severe illnesses often require enteral feeding.

2. Adults: Adults with chronic diseases, neurological impairments, or post-surgical conditions represent a significant user base. 3. Geriatrics: The elderly population is a primary demographic for enteral feeding due to age-related health issues.

By End-User

1. Hospitals: The largest end-user segment, where enteral feeding devices are extensively used for inpatient care. 2. Home Care Settings: Growing rapidly due to the increasing preference for home-based care. 3. Ambulatory Care Centers: These centers utilize enteral feeding devices for outpatient procedures and short-term care.

Regional Analysis

The enteral feeding devices market is geographically diverse, with significant growth observed in North America, Europe, Asia-Pacific, and the rest of the world.

1. North America: Dominates the market due to the high prevalence of chronic diseases, advanced healthcare infrastructure, and substantial healthcare expenditure. 2. Europe: Follows closely with a well-established healthcare system and increasing awareness about enteral feeding benefits. 3. Asia-Pacific: Expected to witness the fastest growth due to improving healthcare infrastructure, rising geriatric population, and increasing healthcare expenditure. 4. Rest of the World: Includes regions with emerging markets showing potential growth due to improving healthcare services.

Future Prospects

The future of the enteral feeding devices market looks promising with ongoing technological advancements and increasing awareness about the benefits of enteral nutrition. Key players in the market are focusing on developing innovative products and expanding their geographical presence through strategic collaborations and acquisitions.

Key Players

Conmed Corporation

C.R.Bard

Cook Medical

Boston Scientific Corporation

Moog Inc.

Fresenius Kabi AG

Danone Medical Nutrition

Kimberly-Clark

Abbott Nutrition

B Braun Melsungen AG

Avanos Medical, Inc.

Cardinal Health

Applied Medical Technology, Inc.

Vygon India

Fidmi Medical

ALCOR Scientific

Amsino International, Inc.

Others

Segmentation

By Product Type

Enteral Feeding Tubes

Nasogastric Tubes (NG Tubes)

Nasojejunal Tubes (NJ Tubes)

Gastrostomy Tubes (G Tubes)

Jejunostomy Tubes (J Tubes)

Percutaneous Endoscopic Gastrostomy Tubes (PEG Tubes)

Percutaneous Endoscopic Jejunostomy Tubes (PEJ Tubes)

Others

Enteral Feeding Pumps

Gravity Feeding Sets

Syringe Pumps

Electric Feeding Pumps

Ambulatory Feeding Pumps

Others

Giving Sets

Enteral Syringes

Administration Reservoirs

Accessories (Extension Sets, Connectors, Caps, etc.)

By Age Group

Pediatric

Adult

By Application

Oncology

Gastroenterology

Neurology

Critical Care

Diabetes

Geriatrics

Others

By End User

Hospitals

Ambulatory Surgical Centers

Long-term Care Centers

Home Care Settings

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/enteral-feeding-devices-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[bhushans]

Exploring New Technologies in the Enteral Feeding Devices Market

The enteral feeding devices market is set for steady growth, with a projected compound annual growth rate (CAGR) of 4.0% over the forecast period. According to recent market analysis, the market is expected to increase from USD 2.8 billion in 2023 to USD 4.1 billion by 2033, reflecting the growing demand for efficient and reliable enteral feeding solutions.

Enteral feeding devices, essential for providing nutrition to patients who cannot consume food orally, are increasingly in demand due to the rising prevalence of chronic diseases, aging populations, and advancements in medical technology. These devices play a crucial role in patient care, particularly in hospitals, long-term care facilities, and home healthcare settings.

The market’s growth is driven by the continuous innovation and improvement in enteral feeding technologies, ensuring better patient outcomes and enhanced quality of care. Key players in the industry are focusing on developing more efficient, user-friendly, and safe enteral feeding solutions to meet the evolving needs of healthcare providers and patients.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

The promising future of the enteral feeding device market highlights its vital function in the healthcare industry in providing for the nutritional requirements of patients unable to swallow food. With consistent expansion and ongoing innovation, the industry is poised to significantly advance patient care across the globe.

Key Takeaways:

Market Growth: The enteral feeding devices market is projected to grow at a CAGR of 4.0% from 2023 to 2033.

Current and Future Valuation: The market holds a current valuation of US$ 2.8 billion in 2023 and is expected to reach US$ 4.1 billion by 2033.

Driving Factors: Key drivers of this growth include rising incidences of chronic diseases, technological advancements in medical devices, and an aging global population necessitating increased nutritional support.

Market Dynamics: The market dynamics are influenced by healthcare providers’ increasing focus on homecare settings, enhancing patient comfort and reducing hospital stays.

Enteral Feeding Devices Market — Regional Analysis

North America and Europe are expected to cumulatively account for nearly 70% of overall market value, with the former holding 40% of the share.

The dominance of these regions is attributed to favorable medical policies and the strong presence of market players.

Asia Pacific is forecasted to register tremendous growth on the back of rising healthcare expenditure, the presence of a large patient pool, and a burgeoning number of preterm births.

Enteral Feeding Devices Market — Competitive Landscape

Major market players operating in the market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company, and Dynarex Corporation among others. Market players are focusing on developing innovative products with low weight to increase portability.

On these lines, Infinity Feeding Pumps launched the Zevex EnteraLite Infinity Feeding Pump, which weighs less than one pound.

Key Contributors:

Abbott Nutrition

ALCOR Scientific

Applied Medical Technology

B. Braun Melsungen AG

Boston Scientific

CONMED Corporation

Cook Medical

Cardinal Health, Inc.

Becton, Dickinson, and Company

Fresenius Kabi

Owens & Minor, Inc. (Halyard Health)

Medline

Moog

Nestlé Health Science

Danone SA

Vygon SA

Amsino International, Inc.

Fuji Systems Corp

Neomed

Smiths Medical (Smiths Group)

Key Segments:

By Product Type:

Enteral Feeding Pumps

Nasogastric Tubes

Nasojejunal Tubes

Percutaneous Endoscopic Gastrostomy (PEG) Kit

PEG Balloon Kit

PEG Non-Balloon Kit

Replacement G-Tubes

Replacement Balloon G-Tubes

Replacement Non-Balloon G-Tubes

Percutaneous Endoscopic Gastro-Jejunostomy (PEGJ) Tubes

Low-profile Tubes

Low-profile Balloon Tubes

Low-profile Non-Balloon Tubes

By Age Group:

Adult

Pediatric

By End User:

Hospital

Clinic

Ambulatory Surgical Center

Home Care Setting

By Region:

North America

Latin America

Europe

Asia Pacific (APAC)

The Middle East & Africa (MEA)

[meghanester]

Nasogastric Tube Market Growth with a CAGR of Approximately 6% During 2023-2035 and Attain Around USD 1000 Million by 2035

Research Nester’s recent market research analysis on “Nasogastric Tube Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the global nasogastric tube market in terms of market segmentation by tube, patient group, indication, end user, and by region.

Growing Admission of Patients in ICU to Promote Global Market Share of Nasogastric Tube

The global nasogastric tube market is slated to grow majorly on account of the rising demand for ICUs from critical patients and higher cases of chronic diseases. People hospitalized in the ICU are in critical condition and have difficulty swallowing medications. These medications are administered via a nasogastric tube. Some patients acquire pneumonia during the course of COVID-19, with typical abnormalities on chest CT. This resulted in significant breathing issues, food swallowing, and other issues. Patients with severe symptoms are transferred to the intensive care unit (ICU), where mechanical ventilation is frequently required. The covid patients' preexisting chronic conditions exacerbated their situation. Moreover, nasogastric tubes can be used to drain excess fluid or prevent aspiration in some chronic diseases, such as pancreatic disorders or ailments with significant fluid accumulation in the belly. According to the World Health Organization, noncommunicable illnesses kill over 41 million people each year. 17 million of whom die before the age of 70. Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-5016

Besides this, the market growth is also attributed to growing cases of surgical procedures followed by increasing demand for enteral feeding. A nasogastric tube is introduced during surgery to remove accumulated air, fluid, or gastrointestinal contents from the stomach. Furthermore, the body is too weak to absorb and swallow solid foods when recovering after surgery. Enteral feeding is thus employed to give appropriate therapeutic nutrition. Moreover, nasogastric tubes are a reasonably easy and non-invasive technique of enteral feeding in the intensive care unit. They are a temporary solution that is easy to implement.

Some of the major growth factors and challenges that are associated with the growth of the global nasogastric tube market are:

Request for customization @ https://www.researchnester.com/customized-reports-5016

Growth Drivers:

• Surging Demand for Enteral Feeding

• Rising Cases of ICU Admissions and Surgery

Challenges: There are various different methods that can be used for enteral feeding and there are no proper reimbursement policies for the manufacturers of nasogastric tubes are some of the major factors anticipated to hamper the global market size of nasogastric tube. There are alternative methods for enteral feedings, such as gastronomy tubes, or jejunostomy tubes, which may be preferred over nasogastric tubes in certain patient populations. On the other hand, the infection caused by these tubes is also expected to stifle market expansion. Infections such as bloodstream infections and pneumonia might be increased by improper insertion, inadequate care, or prolonged use of the tube. These all problem cause discomfort and irritation for patients.

On the basis of tubes, the global nasogastric tube market is segmented into levin catheter, dobhoff tube, sengstaken-blakemore tube. The Levin catheter segment is to accumulate the maximum revenue through 2035, by growing at a significant CAGR in the upcoming years. The Levin catheter is becoming highly popular, owing to better health services provided at hospitals, which aids the treatment of the situation that increases the need for nasogastric tubes. Moreover, by patient group, the market is fragmented into geriatric and adults, the geriatric segment will grow significantly owing growing population of old adults. Older people have difficulty ingesting appropriate nutrients orally for a variety of reasons, including weak appetites and medical issues. Nasogastric tubes aid in their hydration and nutritional maintenance.

Obtain this Report @ https://www.researchnester.com/reports/nasogastric-tube-market/5016

By region, the North American nasogastric tube market is to generate the highest revenue between 2023 and 2035. Market expansion is anticipated to be fueled by rising admission to ICU and the establishment of various regulatory rules. More than 6 million people are admitted to an intensive care unit (ICU) in the United States each year. Moreover, by late June/early July 2020, overall non-COVID-19 admissions in the United States had grown to 16 percent of pre-pandemic baseline volume. Furthermore, the regulatory guidelines will promote the manufacturing of better and high-quality products, which will aid in market growth.

This report also provides the existing competitive scenario of some of the key players of the global nasogastric tube market which includes company profiling of QMD, Angiplast Pvt. Ltd., Securmed, Vygon SAS, Medtronic, Andersen Products Ltd., Cardinal Health, Baihe Medical, and Poly Medicure Limited.

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[latestanalysis]

Global Medical Nasogastric Tubes Market Top Manufactures Swot Analysis, Size, Share, Relevant Growth Report Analysis 2020-2027

Qualiket Research delivers a latest published report on Global Medical Nasogastric Tubes Market industry analysis and forecast 2020 �� 2027 providing a key insights and competitive advantage to clients through a detailed report. The global Medical Nasogastric Tubes Market exhibit steady growth throughout the forecast period. Several market drivers and restraints are analysed in the report, which delivers readers with a clear image of what’s driving and what’s holding back the Medical Nasogastric Tubes Market. The historical trajectory of the market is examined in the report in the report in order to provide a basis for predictions regarding the market’s growth rate during the forecast period.

Impact of COVID-19 on Market

Growing number of COVId-19 patients with respiratory failure is expected to accelerate the demand for medical nasogastric tubes market growth during this forecast period. The outbreak of COVID-19 has been increasing at an exponential rate. This has led to the need to improve patient care & offer added nutritional support to patients affected by the virus.

Request Sample of This report @ https://qualiketresearch.com/request-sample/Medical-Nasogastric-Tubes-Market/request-sample

Key Players

Some of the key players are listed in the report such as Guangdong Baihe Medical Technology, Bicakcilar, Bard Medical, Pacific Hospital Supply Co. Ltd, Andersen Products, Degania Medical, Cardinal Health, Cook Medical, Rontis Medical,Poly Medicure Limited, etc.

Market Taxonomy

By Type

· Levin Catheter

· Dobhoff Tube

· Sengstaken- Blakemore Tube

· Others

By Patient

· Pediatric

· Adult

By End user

· Hospitals

· Clinics

· Others

By Region

· North America

· Latin America

· Europe

· Asia Pacific

· Middle East & Africa

Browse Full This Report @ https://qualiketresearch.com/reports-details/Medical-Nasogastric-Tubes-Market

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

[researchinhealthcare]

Esophageal Dysphagia Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2027

Esophageal Dysphagia Market Highlight :

The esophageal dysphagia market is expected to witness tremendous growth owing to the rising prevalence of oral cancer. Other key factors such as the change to sedentary lifestyle, increase in smoking and increasing of fungal infection are contributing towards the growth of the market.

However, factors such as the high cost of surgical procedures, the allergic reaction of medication and the side effects associated with treatments are expected to restrict the market growth during the forecast period.

Esophageal Dysphagia Market Segmentation :

The global esophageal dysphagia market is segmented on the basis of diagnosis, treatment, products, and end-user. The esophageal dysphagia market, by diagnosis, is categorized into X-ray, Dynamic swallowing study, Endoscopy, Manometry and Imaging scans. Imaging scans is sub-segmented into MRI scan, CT scan. On the basis of treatment, the market is segmented into esophageal dilation, surgery, medications, lifestyle changes. Surgery is sub-segmented into stent placement, and laparoscopic heller myotomy.

On the basis of products, the market is segmented into feeding tube, nutritional solutions and drugs. Feeding tube is sub-segmented into the nasogastric tube, percutaneous endoscopic gastrostomy. Nutritional solutions are sub-segmented into thickeners, beverages, and purees. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others.

Esophageal Dysphagia Market Regional Analysis :

The Americas is the largest in the market owing to the increasing prevalence of cardiac diseases, trauma to the neck, head, or spine and growing healthcare expenditure. Other risk factors for esophageal dysphagia are human papillomavirus, Plummer-Vinson syndrome and irradiation of the esophagus. According to the Genital HPV Infection, (GHI) Fact Sheet 2017, 79 million American adults were infected with human papillomavirus. Such a high incidence of (HPV) drives the market growth in this region.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/6464

Europe (UK, Belgium, France, and Netherlands) is expected to be the second largest esophageal dysphagia market during the forecast period. The increasing occurrence of cancer drives the market in this region. According to Cancer Research UK in 2015, there were 359,960 new cases of cancer. Thus, the growing cases of cancer facilitate the market growth.

Asia-Pacific was projected to be the fastest growing region for the global esophageal dysphagia market in 2017. The market is expected to witness growth owing to the rising prevalence of alcohol ingestion and smoking in this region. According, to the World Health Organization in 2015, 47.6% and 33.7% of people smoked tobacco in China and Japan, respectively. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, the rising oncology and palliative care services both at the hospital level and in the community are expected to influence the market in a positive way.

Esophageal Dysphagia Market Key Players :

Some of the key players in the global esophageal dysphagia market are Merck Sharp & Dohme Corp., Biostagel, Torax Medical, Inc., NinePoint Medical, Inc., Elekta AB, Eisai Co Ltd, Cipla Ltd., AstraZeneca Plc, Kent Precision Foods Group, Inc., Nestlé Health Science France, Nutricia Ltd, C.R. Bard, Inc., Cook Medical Incorporated, and others.

Access Report @ https://www.marketresearchfuture.com/reports/esophageal-dysphagia-market-6464

[meditech-insights]

Enteral Feeding Devices Market to Significantly Increase Revenues Through 2026

Nutrition plays an important role in maintaining health as well as in the prevention and management of a variety of diseases. Enteral feeding is the delivery of nutrients directly into the digestive tract through a feeding tube. 

The Enteral Feeding Devices Market is expected to grow at a rate of ~6% by 2026. The increasing prevalence of chronic diseases, rising demand for enteral feeding devices in-home care settings, growing adoption of enteral nutrition, rising geriatric population, an increasing number of preterm births, shift from parenteral to enteral nutrition, and growing awareness regarding enteral nutrition are some of the key factors driving the global enteral feeding devices market.

Enteral feeding devices are devices that are placed in patients who have a functional and accessible gastrointestinal (GI) tract but are not able to consume or absorb enough nutrients to sustain adequate nutrition and hydration. For many individuals, enteral nutrition support is a lifesaving modality to prevent or treat a depleted nutrient state that can lead to tissue breakdown, compromised immune function, and poor wound healing. The main types of enteral feedings devices available in the market are nasogastric tube (NGT), orogastric tube (OGT), gastrostomy tube, jejunostomy tube, nasoenteric tube, and oroenteric tube.

A Move towards Enteral Nutrition from Parenteral Nutrition Drives the Enteral Feeding Devices Market

In general, medical providers typically recommend enteral feeding over parenteral feeding. This is due to enteral nutrition being less costly, easier on the body, and presents fewer complications. For people recovering from an illness or injury, it presents a safe and effective way to maintain energy and promote healing. Moreover, feeding tubes are easier to clean and sterilize than IVs, catheters, or ports.

Rising Adoption of Home Enteral Nutrition (HEN) Fuels the Demand

HEN can be recommended for a diversity of people with many different conditions and circumstances. Enteral nutrition is started during a hospital stay and continued as a long-term home enteral nutrition therapy. Because of the increasing expenses in the hospital, HEN is considered quite an essential cost-effective and safe treatment for patients who require continuous nutritional support after being discharged. Thus, increased adoption of HEN in-home care is expected to fuel the demand for the enteral feeding devices market in the coming period.

Key Constraints/ Challenge of Enteral Feeding Devices Market

Reimbursement issues and complications associated with enteral feeding tubes are some of the key factors that are likely to hamper the growth of the market. Some of the complications associated with enteral feeding devices are skin irritation, aspiration, refeeding syndrome, nausea, vomiting, diarrhoea, tube blockage, and tube dislodging.

Get Customized Report on Enteral Feeding Devices @ https://meditechinsights.com/enteral-feeding-devices-market/

North America Expected to Continue Holding Major Share in the Enteral Feeding Devices Market

North America currently holds a major share in the global enteral feeding devices market. It is expected to continue to hold a major share in the coming years due to the growing prevalence of chronic diseases, rising aging population, adoption of technologically advanced products, and growing awareness regarding enteral nutrition in the region.

Competitive Landscape: Enteral Feeding Devices Market

Some of the key players operating in Enteral Feeding Devices market include Danone, B. Braun Melsungen AG, Cook Medical, Conmed Corporation, BD, Abbott Laboratories, Vygon SA, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Players operating in this market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. For instance, 

•In March 2022, Vygon SA announced the acquisition of Macatt Medica, a distribution company located in Lima, Peru. The company distributes the majority of Vygon’s products in Peru, including a wide range of enteral nutrition products

•In February 2022, Alcor Scientific announced that they have entered into a strategic partnership with health care investor Water Street Healthcare Partners where Water Street will invest capital in Alcor’s expansion

Competitive Landscape: Enteral Feeding Devices Market

Some of the key players operating in Enteral Feeding Devices market include Danone, B. Braun Melsungen AG, Cook Medical, Conmed Corporation, BD, Abbott Laboratories, Vygon SA, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[healthcare-market]

Sodium Phenylbutyrate Drugs Market Estimated to Expand at a Robust CAGR by 2025

Sodium Phenylbutyrate Drugs Market: Introduction

Sodium phenylbutyrate drugs are prescribed for adjunctive therapy in the chronic management of urea cycle disorders. They are primarily administered orally, in equally divided doses, with each meal or feeding. Divalproex (Depakote), haloperidol (Haldol), valproic acid (Depakene, Stavzor) may interact with sodium phenylbutyrate, if taken simultaneously. Buphenyl is a brand name of sodium phenylbutyrate, approved by the FDA.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79557

Key Drivers and Restraints of Global Sodium Phenylbutyrate Drugs Market

· Urea cycle disorders (UCDs) are inborn errors of metabolism (IEMs) resulting from defects in any 1 of the six enzymes or 2 transporters involved in the hepatic removal of ammonia from the bloodstream by conversion to urea, which is excreted by the kidneys. UCDs include carbamoyl phosphate synthase (CPS) deficiency, ornithine transcarbamylase (OTC) deficiency, argininosuccinate synthetase deficiency (citrullinemia), argininosuccinate lyase deficiency (argininosuccinic aciduria), and arginase deficiency (argininemia). Overall incidence of UCD, globally, varies from 1:8000 to 1:44,000 births. An estimated cumulative incidence of UCDs in Europe is approximately 1 in 51,946. Sodium phenylbutyrate drugs are utilized for the treatment of urea cycle disorders. Thus, an increase in cases of UCDs fuel the market.

· Increased research & development initiatives undertaken by research & academic institutes supported by pharmaceutical companies as well as governments are estimated to drive sodium phenylbutyrate drugs market

· Side effects related to the intake of sodium phenylbutyrate drugs may hamper the market. Common side effects may include missed menstrual periods or changes in the regular cycle, loss of appetite, headache, nausea or vomiting, lower back, side, or stomach pain.

Request a Sample of Sodium Phenylbutyrate Drugs Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79557

Oral Segment Witness Highest Growth

· Based on route of administration, the global sodium phenylbutyrate drugs market can be divided into oral and nasogastric intubation

· The oral segment accounted for a prominent share of the market in 2019. Sodium phenylbutyrate is available in tablet or powder form. Nasogastric intubation involves the insertion of a plastic tube through the nose, past the throat, and down into the stomach. Nasogastric tube (NGT) insertion is done through anesthetized procedure for critically ill patients who cannot swallow a tablet through oral intake.

Request for Analysis of COVID19 Impact on Sodium Phenylbutyrate Drugs Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79557

Hospital Pharmacies to Dominate Global Sodium Phenylbutyrate Drugs Market

· Based on distribution channel, the global sodium phenylbutyrate drugs market can be divided into: hospital pharmacies, online and retail pharmacies

· In terms of revenue, the hospital pharmacies segment accounted for a notable share of the global market in 2019, followed by the retail pharmacies segment. Within a hospital, the hospital pharmacy dispenses inpatient medications. Hospital pharmacies usually stock a larger range of medications. Expansion of hospital pharmacies is attributed to offering quality medicines to patient by purchasing directly from drug manufacturers, thus preventing the issues of counterfeit medicines.

· The online segment is estimated to expand at a significant CAGR during the forecast period. Increasing penetration of internet, worldwide, rising investments made by private companies, and an increase in the number of steps taken by government bodies are major factors propelling the segment

Enquiry before Buying Sodium Phenylbutyrate Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79557

North America to Dominate Global Sodium Phenylbutyrate Drugs Market

· In terms of region, the global sodium phenylbutyrate drugs market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

· In terms of revenue, North America dominated the sodium phenylbutyrate drugs market. Increase in incidence of urea cycle disorders, rise in number of FDA approvals, and continuous merger & acquisition between companies contribute to the leading share held by the region. According to data published in NCBI in 2013, incidence of urea cycle disorders is at 1 in 35,000 live births in the U.S. or about 113 new patients per year.

· The sodium phenylbutyrate drugs market in Asia Pacific is anticipated to be driven by an increase in the number of target patients, rise in healthcare expenditure, and investments by various companies in research & development activities in the region.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.co.uk/news-releases/growth-in-older-population-drives-demand-opportunities-in-surgical-drainage-devices-market-tmr-879678955.html

https://www.prnewswire.com/news-releases/new-models-in-organoids-market-open-new-vistas-in-stem-cell-research-for-cancer-global-valuation-to-reach-us-12-8-bn-by-2030-tmr-301206242.html

https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[industryinsights]

Ticagrelor Market Scope, Size, Revenue Analysis, Industry Outlook, Forecast Till 2027

Ticagrelor Market Scope, Revenue Forecast, Competitive Landscape, Growth Factors, and Trends: Information by Dosage (Mg) (90 MG and 60 MG), Route of Administration (Oral and Nasogastric Tube), Application (Acute Coronary Syndrome and Heart Surgeries (Angioplasty, Stent Placement and Coronary Artery Bypass Graft)) End User (Hospitals and Clinics and Ambulatory Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa)

According to a leading research firm - Market Research Future (MRFR), the global Ticagrelor Market is poised to register a valuation of USD 2554.39 MN by 2027. In its newly published study report, MRFR also asserts that the market would post a CAGR of 9% throughout the review period (2017 – 2027). Ticagrelor drugs are primarily used in the treatment of cardiovascular disorders and other heart conditions, including diseased vessels, structural problems, and blood clots. In acute coronary syndrome, the combination of ticagrelor and aspirin is reported to have reduced the rate of vascular deaths and myocardial infarctions. As a result, ticagrelor drugs garner a vast market prominence and its market witnesses pervasive growth. Increasing occurrences of cardiovascular disorders is a dominant driving force behind the growth of the market. Besides, the rise in the geriatric population has a direct impact on the growth of the market. 

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/820

Additionally, increasing occurrences of obesity are encouraging the market demand, fuelling the cardiovascular patient pool. Also, growing numbers of drug manufacturers are driving the growth of the market, bringing novel medications in the market. Substantial investments transpired into R&D activities driven by improving economic conditions provide impetus to the growth of the market. 

Conversely, factors impeding the growth of the market, include patent expiries and side effects of Ticagrelor such as bleeding that can sometimes go worst, leading to death. Nevertheless, factors such as substantial technological strides that increase the efficacies of Ticagrelors would support market growth, increasing market demand. 

 Global Ticagrelor Market – Segments

The report is segmented into five market dynamics to widen the scope of understanding,

By Dosage: 90 Mg and 60 Mg.

By Route of Administration: Oral and Nasogastric Tube.

By Route of Application: Acute Coronary Syndrome, Heart Surgeries, Angioplasty, Stent Placement, and Coronary Artery Bypass Graft, among others.

By End-user: Hospitals & Clinics and Ambulatory Centers, among others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global Ticagrelor Market – Regional Analysis

North America leads the global Ticagrelor market with the largest market share. Heading with the rising geriatric population that is highly prone to degenerative diseases and prevalent chronic diseases, the region is estimated to retain its dominance throughout the forecast period. Additionally, the presence of a well-developed healthcare sector, alongside, the high per capita healthcare expenditures and well-spread awareness drive the regional market growth. 

Growing markets in the US and Canada backed by the presence of prominent market players, positively impact the growth of the Ticagrelor market in the region. Furthermore, increasing diagnosis and therapeutics would support the market to create a significant revenue pocket during the assessment period (2017-2027). 

The Ticagrelor market in the European region accounts for the second-largest market, globally. The rising patient population of strokes & cardiovascular disorders and the introduction of advanced & integrated treatment options are expected to boost the regional market growth. 

Moreover, factors such as favorable government support for researches on antiplatelets, availability of advanced treatment facilities, and increasing healthcare expenditure, foster the growth of the market in the region. The UK, backed by its sizeable Ticagrelor market and Germany with its vast medical technology and pharmaceutical industry, contribute to the growth of the regional market, significantly.

The Asia Pacific Ticagrelor market is rapidly emerging as a promising market globally. Factors like increasing per capita disposable income and government initiatives to enhance the quality of healthcare drive the regional market growth. Moreover, the burgeoning pharmaceutical industry in this region is predominantly influencing the growth of the APAC Ticagrelor market.

Additionally, spreading awareness towards the disorder and the availability of novel treatment procedure to manage the condition influence the growth of the regional market, positively. Furthermore, the rising prevalence of cardiovascular diseases led by the changing lifestyles alongside, the continually rising healthcare expenditures and favorable government policies substantiate the market growth in the APAC region.

Global Ticagrelor Market – Competitive Analysis

Fiercely competitive, the Ticagrelor market appears to be fragmented due to the presence of many players. Large and small players alongside, the new entrants form a competitive landscape. They try to gain a substantial market share through strategic initiatives such as mergers & acquisitions, expansion, collaboration, and product/ technology launch.

 Major Players: 

Players leading the global Ticagrelor market include Eli Lilly, AstraZeneca, Boehringer, Pfizer, Ingelheim, Amgen, Roche, Merck, GSK, Ingelheim Pfizer, Alexion, Boehringer, and Amgen, among others. 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/ticagrelor-market-820

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[vicky8588]

Acute Coronary Syndrome Market

Market Overview

The Global “Acute Coronary Syndrome Market" is expected to grow at a high CAGR of 11.70% during the forecast period (2021-2028).

 Acute coronary syndrome (ACS) refers to a spectrum of clinical presentations ranging from ST-segment elevation myocardial infarction (STEMI) to presentations found in non–ST-segment elevation myocardial infarction (NSTEMI) or in unstable angina.

 It is associated with rupture of an atherosclerotic plaque and partial or complete thrombosis of the infarct-related artery.

 Acute coronary syndrome (ASC) occurs when a blood clot suddenly forms within a coronary artery, usually due to the acute rupture of an atherosclerotic plaque.

 The blood clot may produce partial or complete blockage of the artery, either way placing the heart muscle supplied by that artery in immediate jeopardy.

Download Free Samples @ https://www.datamintelligence.com/download-sample/acute-coronary-syndrome-market

 Market Dynamics

The increasing cases of hypertension are one of the factors fueling the global acute coronary syndrome market.

 High blood pressure is the main risk factor for stroke and risk factor for heart attack, heart failure, and kidney disease. There is also increasing evidence that it is a risk factor for vascular dementia.

 For instance, according to the Center for Disease Control and Prevention (CDC), around 75 million American adults with 32% have high blood pressure in 2016. 1 in 3 American adults has prehypertension.

 According to the National Heart Foundation of Australia, in 2015, 6 million Australians aged 18 years and over had high blood pressure.

 In 2015, the prevalence of uncontrolled or unmanaged high blood pressure was 20.4% in Western Australia and 25.2% in Tasmania.

 According to the Blood Pressure Association, around 16 million people in the UK have high blood pressure, of which 30% of women and 32% of men have high blood pressure in 2016.

 In 2016, around 62,000 death cases from stroke and heart attacks occurred due to poor blood pressure control.

 The risk for AFib increases with age. High blood pressure, which also increases in danger with advancing age, accounts for 14% to 22% of AFib cases.

 More than 750,000 hospitalizations occur each year because of AFib. The condition contributes to an estimated 130,000 deaths each year.

 Segmentation Analysis

Based on the type the global market for acute coronary syndrome is broadly segmented as by ST-elevation myocardial infarction, non-ST elevation myocardial infarction, and unstable angina.

 Currently, ST-elevation myocardial infarction is showing significant growth, and it accounts for approximately XX% of the market, due to the regulatory approval for ST-elevation myocardial infarction drugs.

 For instance, in January 2018, Wacker Biotech GmbH has received US Food and Drug Administration (FDA) approval to manufacture the drug substance in Retavase, a thrombolysis medication. The medication is used to treat acute myocardial infarction in adults. The drug Retavase used to treat acute ST-elevation myocardial infarction (STEMI).

 In March 2016 AstraZeneca received US Food and Drug Administration (FDA) approval for a new administration option for acute coronary syndrome (ACS) patients. BRILINTA is indicated to reduce the rate of thrombotic cardiovascular (CV) events in patients with ACS ST-elevation myocardial infarction [STEMI]. BRILINTA to be crushed and administered in water by swallowing or via nasogastric tube.

 Geographical Analysis

The global Acute Coronary Syndrome market is segmented into North America, Europe, Asia Pacific, South America, and ROW.

 North America is dominating the global Acute Coronary Syndrome market, the rising prevalence of hypertension, which is driving the market.

 For instance, according to the American Heart Association, in 2017, an estimated 103 million U.S. adults have high blood pressure.

 According to American Heart Association, the death rate from high blood pressure increased by nearly 11% in the United States between 2005 and 2015, and the actual number of deaths rose by almost 38%, which is up to almost 79,000 by 2015.

View Full Report @ https://www.datamintelligence.com/research-report/acute-coronary-syndrome-market

 Competitive Trends

The strategic alliance between companies and regulatory approval for acute coronary syndrome is one of the key factors driving the global Acute Coronary Syndrome market.

 For instance, in November 2018, AstraZeneca has received the US Food and Drug Administration (FDA) approval for the first generic medication indicated for lowering the risk of heart attack, or death from a heart attack or stroke in patients with the acute coronary syndrome (ACS).

 Ticagrelor tablets, a generic version of Brilinta have been granted Abbreviated New Drug Application (ANDA) approval in 60 mg and 90 mg doses.

 In June 2015, Roche entered into an agreement with DalCor to develop a companion diagnostic (CDx) test for dalcetrapib, which will target patients with a specific genotype experiencing acute coronary syndrome (ACS).

 In June 2015, Sun Pharmaceutical Industries signed an agreement with AstraZeneca Pharma to distribute the cardiology drug Axcer in India. Axcer is an additional brand of Astra drug ticagrelor that is used in treating acute coronary syndrome (ACS).

For Enquiry @ https://www.datamintelligence.com/enquiry/acute-coronary-syndrome-market

 About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

 For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website: www.datamintelligence.com

[press-release-dash]

Contactless Payments Market 2021 | Business Opportunity, Growth Strategies & Forecast Report By 2027

The Global Contactless Payments Market Report, in its latest update, highlights the significant impacts and the recent strategically changes under the present socio-economic scenario. The Contactless Payments industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry. The report starts with the executive summary, followed by a value chain and marketing channels study. The report then estimates the CAGR and market revenue of the global and regional segments.

Base Year: 2020

Estimated Year: 2021

Forecast Till: 2027

The report classifies the market into different segments based on type and product. These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels. The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.

Get | Download FREE Sample Report of Global Contactless Payments Market @ https://www.decisiondatabases.com/contact/download-sample-4994

A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Contactless Payments market.  The impact is closely studied in terms of production, import, export, and supply.

The report covers the complete competitive landscape of the Worldwide Contactless Payments market with company profiles of key players such as:

3M Company

Braun Melsungen AG

Baxter International, Inc.

C. R. Bard, Inc.

Centurion Medical Products

Convatec, Inc.

M. C. Johnson Company, Inc.

Medtronic PLC

Merit Medical Systems, Inc.

Smiths Group PLC

Want to add more Company Profiles to the Report? Write your Customized Requirements to us @ https://www.decisiondatabases.com/contact/get-custom-research-4994

Contactless Payments Market Analysis by Product:

Arterial Devices Securement Devices

Central Venous Catheter Securement Devices

Peripheral Securement Devices

Abdominal Drainage Tubes Securement Device

Epidural Securement Devices

Chest Drainage Tube Securement Device

All Site Device

PICC Securement Devices

Subclavian Securement Devices

Jugular Securement Devices

Femoral Securement Devices

Portal Securement Devices

Midlines Securement Devices

Foley Catheter Securement Devices

Nasogastric Tubes Securement Devices

Endotracheal Tube Securement Devices

Continuous Nerve Block Catheter Securement Devices

Ventriculoperitoneal Shunt Securement Devices

Percutaneous Endoscopic Gastrostomy Securement Device

Umbilical Catheter Securement Device

Jejunal Catheter Securement Device

Catheter Stabilization Device / Catheter Securement Devices Market Analysis by Applications:

General Surgery

Cardiovascular Procedures

Respiratory Procedures

Urological Procedures

Gastric and Oropharangeal Procedures

Radiology

Other Applications

Catheter Stabilization Device / Catheter Securement Devices Market Analysis by End User:

Hospitals

Emergency Clinics

Home Healthcare Providers

Diagnostic Centers

Contactless Payments Market Analysis by Geography:

North America (USA, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Russia, Spain, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Australia, South-East Asia, Rest of Asia-Pacific)

Latin America (Brazil, Argentina, Peru, Chile, Rest of Latin America)

The Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of the Middle East and Africa)

Key questions answered in the report:

What is the expected growth of the Contactless Payments market between 2022 to 2027?

Which application and type segment holds the maximum share in the Global Contactless Payments market?

Which regional Contactless Payments market shows the highest growth CAGR between 2022 to 2027?

What are the opportunities and challenges currently faced by the Contactless Payments market?

Who are the leading market players and what are their Strengths, Weakness, Opportunities, and Threats (SWOT)?

What business strategies are the competitors considering to stay in the Contactless Payments market?

Purchase the Complete Global Contactless Payments Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-4994

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/

[bhushans]

Beyond Diagnosis: Exploring Global Enteral Feeding Devices Market

The global enteral feeding devices market is poised for significant growth over the next decade, expanding at an average compound annual growth rate (CAGR) of 4.0% during the forecast period. In 2023, the market is valued at approximately USD 2.8 billion and is projected to reach an estimated USD 4.1 billion by 2033.

This robust growth trajectory is driven by several key factors, including increasing prevalence of chronic diseases, rising geriatric population, and advancements in medical technology. The growing awareness about the benefits of enteral feeding in improving patient outcomes, particularly in critical care settings, further supports the market expansion.

As the market evolves, industry leaders are expected to focus on innovative product development and strategic partnerships to cater to the increasing demand for efficient and reliable enteral feeding solutions. The ongoing investments in research and development are likely to result in more user-friendly and technologically advanced feeding devices, enhancing patient comfort and care quality.

Request Your Detailed Report Sample With Your Work Email : https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

The enteral feeding devices market’s positive outlook underscores its critical role in the healthcare sector, addressing the nutritional needs of patients who cannot consume food orally. With sustained growth and continuous innovations, the market is set to make significant strides in improving patient care worldwide.

Key Takeaways:

Market Growth: The enteral feeding devices market is projected to grow at a CAGR of 4.0% from 2023 to 2033.

Current and Future Valuation: The market holds a current valuation of US$ 2.8 billion in 2023 and is expected to reach US$ 4.1 billion by 2033.

Driving Factors: Key drivers of this growth include rising incidences of chronic diseases, technological advancements in medical devices, and an aging global population necessitating increased nutritional support.

Market Dynamics: The market dynamics are influenced by healthcare providers’ increasing focus on homecare settings, enhancing patient comfort and reducing hospital stays.

Enteral Feeding Devices Market — Regional Analysis

North America and Europe are expected to cumulatively account for nearly 70% of overall market value, with the former holding 40% of the share.

The dominance of these regions is attributed to favorable medical policies and the strong presence of market players.

Asia Pacific is forecasted to register tremendous growth on the back of rising healthcare expenditure, the presence of a large patient pool, and a burgeoning number of preterm births.

Enteral Feeding Devices Market — Competitive Landscape

Major market players operating in the market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company, and Dynarex Corporation among others. Market players are focusing on developing innovative products with low weight to increase portability.

On these lines, Infinity Feeding Pumps launched the Zevex EnteraLite Infinity Feeding Pump, which weighs less than one pound.

Key Contributors:

Abbott Nutrition

ALCOR Scientific

Applied Medical Technology

B. Braun Melsungen AG

Boston Scientific

CONMED Corporation

Cook Medical

Cardinal Health, Inc.

Becton, Dickinson, and Company

Fresenius Kabi

Owens & Minor, Inc. (Halyard Health)

Medline

Moog

Nestlé Health Science

Danone SA

Vygon SA

Amsino International, Inc.

Fuji Systems Corp

Neomed

Smiths Medical (Smiths Group)

Key Segments:

By Product Type:

Enteral Feeding Pumps

Nasogastric Tubes

Nasojejunal Tubes

Percutaneous Endoscopic Gastrostomy (PEG) Kit

PEG Balloon Kit

PEG Non-Balloon Kit

Replacement G-Tubes

Replacement Balloon G-Tubes

Replacement Non-Balloon G-Tubes

Percutaneous Endoscopic Gastro-Jejunostomy (PEGJ) Tubes

Low-profile Tubes

Low-profile Balloon Tubes

Low-profile Non-Balloon Tubes

By Age Group:

Adult

Pediatric

By End User:

Hospital

Clinic

Ambulatory Surgical Center

Home Care Setting

By Region:

North America

Latin America

Europe

Asia Pacific (APAC)

The Middle East & Africa (MEA)

[tmr123123]

Dysphagia Management Market Size, Industry & Landscape Outlook, Revenue Growth Analysis to 2030

The Global Dysphagia Management Market held USD 3726.1 million in 2020 and is to grow with a CAGR over 6% from 2020-2030. Dysphagia is “trouble in gulping”, though eating challenges allude to issues related with movement of fluid/food through mouth. These issues exist together in numerous patients. Dysphagia is a typical issue after stroke. As a rule, dysphagia gets settled quickly. In any case, sometimes, the swallow shifts in work. Dysphagia has become a predominant trouble among geriatric populace. Albeit, physiologic changes in swallow work is encouraged by developing age, age-related sicknesses fundamentally add to nearness and seriousness of dysphagia. Gulping recovery is an incredible methodology for furnishing safe oral admission to patients with dysphagia. The advantages of gulping restoration incorporate decreased pneumonia rates, and improve nutritional status

Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/13670

Market Dynamics and Factors:

Expanding predominance of different diseases, particularly oral cancer and neurological reasons for dysphagia, for example, Parkinson’s and Stroke are driving dysphagia management market growth. As per the World Health Organization (WHO), more than 15 million individuals experience the ill effects of stroke worldwide every year. Of these, 5 million mortalities and extra 5 million are for all time handicapped. Hypertension contributes to more than 12.7 million strokes around the world. Additionally, The Oral Cancer Foundation assessed that near 53,000 Americans will be determined to have oral or oropharyngeal related cancer in 2018. It will cause more than 9,750 mortalities, killing around 1 individual for every hour, 24 hours of the day. Notwithstanding, side effects posed by dysphagia drugs are relied upon to hamper dysphagia management industry growth. Additionally, developing predominance and rising interest for nasogastric cylinder and PEG tubes in dysphagia management has created new opportunities for local players to accompany dysphagia management drugs at competitive prices.

Geographic Analysis:

Asia Pacific is anticipated to dominant dysphagia management market during the estimated time period owing to high number of pediatric populaces inside the developing nations, along with, expanding number of medical clinic and retail drug stores additionally add to the accessibility of dysphagia management drugs in the region. As indicated by Economic and Social Commission for Asia and the Pacific (UNESCAP), over 60% of the world’s young population live in Asia-Pacific. This converts into in excess of 750 million young ladies and men between 15 to 24 years.

Enquire for Discount Or Get Customization of Report @ https://www.trendsmarketresearch.com/checkout/13670/Single

North America dysphagia management market will also experience appreciable gains during the forecasted time period. Unnecessary dependence on smoking and alcohol consumption is a major factor contributing to the prevalence of dysphagia-related issues in North America. As indicated by Center of Disease Control and Prevention, in 2017, an expected 14.0% (34.3 million) of U.S. grown-ups were current cigarette smokers. Of these, 75.0% smoked each day.

Market Segmentation:

Based on the type of disease, the dysphagia management market is segmented into on the basis of type, Drugs, Feeding Tubes {PEG Tubes, Naso-Gastric Tubes} and Nutritional Solutions {Beverages, Thickeners, Purees}, On the basis of indication, the dysphagia management market trends varies into Esophageal Dysphagia, Oropharyngeal Dysphagia, and Others. On the basis of distribution channel, the dysphagia management market market is segmented into the Hospital Pharmacies, Retail Pharmacies, Drug Stores, Speciality Clinics and Others. Geographical breakdown and analysis of each of the aforementioned segments in dysphagia management market includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Get Up to 10 % Discount on single User @ https://www.trendsmarketresearch.com/report/discount/13670

Competitive Scenario:

Global dysphagia management market, is highly competitive, consists of a few major players. In terms of dysphagia management market share, few major players are dominating the market. Key companies are also expanding their manufacturing facilities to cater to growing dysphagia management demand globally. Key dysphagia management market players enhancing the global dysphagia management market size include Cipla Ltd., Eisai Co Ltd, AstraZeneca Plc, Nestlé Health Science France, Kent Precision Foods Group, Inc., Nutricia Ltd, Cook Medical Incorporated and C. R. Bard, Inc.

[myoliver123stuff]

Dysphagia Management Market is estimated to reach at $3726.1 million by 2030

Market Overview:

The Global Dysphagia Management Market held USD 3726.1 million in 2020 and is to grow with a CAGR over 6% from 2020-2030. Dysphagia is "trouble in gulping", though eating challenges allude to issues related with movement of fluid/food through mouth. These issues exist together in numerous patients. Dysphagia is a typical issue after stroke. As a rule, dysphagia gets settled quickly. In any case, sometimes, the swallow shifts in work. Dysphagia has become a predominant trouble among geriatric populace. Albeit, physiologic changes in swallow work is encouraged by developing age, age-related sicknesses fundamentally add to nearness and seriousness of dysphagia. Gulping recovery is an incredible methodology for furnishing safe oral admission to patients with dysphagia. The advantages of gulping restoration incorporate decreased pneumonia rates, and improve nutritional status

Market Dynamics and Factors:

Expanding predominance of different diseases, particularly oral cancer and neurological reasons for dysphagia, for example, Parkinson's and Stroke are driving dysphagia management market growth. As per the World Health Organization (WHO), more than 15 million individuals experience the ill effects of stroke worldwide every year. Of these, 5 million mortalities and extra 5 million are for all time handicapped. Hypertension contributes to more than 12.7 million strokes around the world. Additionally, The Oral Cancer Foundation assessed that near 53,000 Americans will be determined to have oral or oropharyngeal related cancer in 2018. It will cause more than 9,750 mortalities, killing around 1 individual for every hour, 24 hours of the day. Notwithstanding, side effects posed by dysphagia drugs are relied upon to hamper dysphagia management industry growth. Additionally, developing predominance and rising interest for nasogastric cylinder and PEG tubes in dysphagia management has created new opportunities for local players to accompany dysphagia management drugs at competitive prices.

Request for Sample with Complete TOC and Figures & Graphs @ https://www.trendsmarketresearch.com/report/sample/13670

Geographic Analysis:

Asia Pacific is anticipated to dominant dysphagia management market during the estimated time period owing to high number of pediatric populaces inside the developing nations, along with, expanding number of medical clinic and retail drug stores additionally add to the accessibility of dysphagia management drugs in the region. As indicated by Economic and Social Commission for Asia and the Pacific (UNESCAP), over 60% of the world's young population live in Asia-Pacific. This converts into in excess of 750 million young ladies and men between 15 to 24 years.

North America dysphagia management market will also experience appreciable gains during the forecasted time period. Unnecessary dependence on smoking and alcohol consumption is a major factor contributing to the prevalence of dysphagia-related issues in North America. As indicated by Center of Disease Control and Prevention, in 2017, an expected 14.0% (34.3 million) of U.S. grown-ups were current cigarette smokers. Of these, 75.0% smoked each day.

Market Segmentation:

Based on the type of disease, the dysphagia management market is segmented into on the basis of type, Drugs, Feeding Tubes {PEG Tubes, Naso-Gastric Tubes} and Nutritional Solutions {Beverages, Thickeners, Purees}, On the basis of indication, the dysphagia management market trends varies into Esophageal Dysphagia, Oropharyngeal Dysphagia, and Others. On the basis of distribution channel, the dysphagia management market market is segmented into the Hospital Pharmacies, Retail Pharmacies, Drug Stores, Speciality Clinics and Others. Geographical breakdown and analysis of each of the aforementioned segments in dysphagia management market includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Direct Purchase this Market Research Report Now @ https://www.trendsmarketresearch.com/checkout/13670/Single

Competitive Scenario:

Global dysphagia management market, is highly competitive, consists of a few major players. In terms of dysphagia management market share, few major players are dominating the market. Key companies are also expanding their manufacturing facilities to cater to growing dysphagia management demand globally. Key dysphagia management market players enhancing the global dysphagia management market size include Cipla Ltd., Eisai Co Ltd, AstraZeneca Plc, Nestlé Health Science France, Kent Precision Foods Group, Inc., Nutricia Ltd, Cook Medical Incorporated and C. R. Bard, Inc.

Get Discount On The Purchase Of This Report @ https://www.trendsmarketresearch.com/report/discount/13670

[rdagade]

Brilinta Market

Brilinta Market size was valued nearly US$ XX Bn. in 2019 and the total revenue is expected to grow at 9.00% through 2019 to 2027, reaching nearly US$ 2554.39 Million by 2027.

To know about the Research Methodology :- Request Free Sample Report

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Brilinta is in a class of antiplatelet medications. It works by averting platelet from collecting and forming clots that may cause a heart attack.The increasing rates of heart attacks and strokes has highly driven the demand of Brilinta in the pharmaceutical industry.

According to the WHO,every year around 17 million people die due to cardiovascular disorders. Such huge number of patients are driving the need of robust preventive measure. Brilinta is also useful for the risk of infection-related diseases.The lung function of the pneumonia patients have shown the good improvement by the study called Targeting Platelet-Leukocyte Aggregates in Pneumonia with Ticagrelor.

The huge no of patients suffering from cardiovascular diseases, greater efficacy of brilinta which results in decrease in people die from stroke, vascular causes and heart attack are some key factors which driving the Brilinta Market.

Though there are a few restraints that may limit the market’s growth. There are some side effects of Brilinta such as bleeding and dyspnea may restrict the use of Brilinta. The research and development of new pharmaceutical compound containing Brilinta molecule and increasing awareness of benefits of Brilinta may drive the global Brilinta molecule.

The North America market for Brilinta is expected to be the largest shareholding market during the forecast period. Europe second highest as per market share. The growth in Gross Domestic Product per capita income and the increasingelderly population which is highly susceptible to chronic diseases which have accelerated the demand for diagnosis and therapeutics are the main factors which are driving the market in this region.

The increasing cases of strokes and cardiovascular diseases, anti-platelets, availability of advanced treatment facilities research, rising healthcare expenditure, and availability of advanced treatment options into the market, also good healthcare infrastructure are some factors which are driving the growth of the market in this region.

Asia-Pacific is likely to be the fastest-growing market of Brilinta due to the increasing per capita disposable incomes, also government initiatives to improve the quality of healthcare. The rising cardiovascular diseases is the major factor which is driving the growth of Brilinta market in this region. The Asia-Pacific region, China accounted for a market share of 28.0% in 2017. Also, the market in the Middle East & Africa is likely to witness steady growth because of limited access to healthcare facilities.

The objective of the report is to present a comprehensive analysis of the Brilinta Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Brilinta Market dynamics, structure by analyzing the market segments and projects the Brilinta Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Brilinta Market make the report investor’s guide.

For more information visit@ https://www.maximizemarketresearch.com/market-report/brilinta-market/75579/

Scope of the Brilinta Market: Inquire before buying

Brilinta Market, by Dosage (MG)

• 90 Mg

• 60 Mg

Brilinta Market, by Route of Administration

• Oral

• Nasogastric Tube

Brilinta Market, by Route of Application

• Acute Coronary Syndrome

• Heart Surgeries

• Angioplasty

• Stent Placement

• Coronary Artery Bypass Graft

Brilinta Market, by End User

• Hospitals & Clinics

• Ambulatory Centers

• Others

Brilinta Market, By Region

• Asia Pacific

• North America

• Europe

• South America

• Middle East & Africa

Key players operating in the Brilinta Market

• Eli Lilly,

• AstraZeneca,

• Boehringer,

• Pfizer,

• Ingelheim,

• Amgen,

• Roche,

• Merck,

• GSK,

• Ingelheim Pfizer,

• Alexion,

• Natco Pharma Limited,

• Anhui Haikang Pharmaceutical Co., Ltd.,

• Avra Laboratories Pvt. Ltd.,

• Sun Pharmaceutical Industries Ltd.

• Others

This report submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908